<DOC>
	<DOCNO>NCT00027209</DOCNO>
	<brief_summary>The goal study evaluate effect synthetic hormone replacement therapy anti-seizure medication level , menopausal symptom relief , seizure frequency safety menopausal woman epilepsy .</brief_summary>
	<brief_title>Hormone Replacement Menopausal Women With Epilepsy</brief_title>
	<detailed_description>This study help answer question regard use hormone replacement therapy woman epilepsy face reach menopause . The total duration study 6 month involve 7 visit doctor . The purpose study discover menopause treatment symptom menopause change epilepsy woman , determine factor present and/or menopause may predict influence menopause woman 's seizure disorder , find possible interaction hormone replacement therapy anti-seizure medication order find optimal dose hormone replacement therapy woman epilepsy .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Subjects must diagnosis partial epilepsy predate onset menopause . Subjects must 010 seizure type per month . Subjects must EEG consistent partial epilepsy diagnosis , show focal abnormality . Subjects must image study brain since diagnosis epilepsy . Subjects must 1 year menopausal ( without menstrual period ) , within 5 year last menstrual period . Subjects must medically clear primary care physician take HRT . Subjects must normal PAP smear within past 9 month . Subjects must mammogram without lesion suspicious malignancy within past 9 month . Subjects caregiver must able keep accurate seizure diary . Subjects must stable current AEDs &gt; 1 month . Subjects must use HRT 3 month prior enrollment . Subjects history breast , uterine ovarian cancer . Subjects treatable reversible cause recurrent seizure ( metabolic , neoplastic , toxic infectious cause ) . Subjects history deep vein thrombosis , arterial thrombosis , pulmonary embolus , blood clotting disorder , stroke . Subjects elevate liver function test two time normal . Subjects 3 first degree family member history breast cancer . Subjects 1 first degree family member history bilateral breast cancer . Subjects history complicate migraine headache . Subjects history unexplained vaginal bleeding . Subjects history familial hyperlipoproteinemia . Subjects history myocardial infarction past 6 month . Subjects diabetes mellitus vascular disease . Subjects untreated hypertension ( &gt; 145/95 3 occasion ) . Subjects history use experimental drug device past 30 day . Subjects severe chronic and/or progressive medical illness . Subjects active drug alcohol abuse . Subjects history discontinuation Prempro past due side effect . Subjects state tolerate 6 month without relief menopausal symptom . Subjects plan change anticipate change antiseizure treatment next 6 month .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2005</verification_date>
	<keyword>seizure</keyword>
	<keyword>epilepsy</keyword>
	<keyword>menopause</keyword>
</DOC>